Karolinska Institutet
Karolinska Institutet is Sweden's largest medical university, conducting the single largest share of the country's academic medical research, hosting the Nobel Assembly, and educating medical students across campuses in Solna and Flemingsberg.
- Company typePrivate
- Founded1810
- HeadquartersSolna, Sweden
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingServices
What Karolinska Institutet does
Karolinska Institutet (KI) is Sweden's largest medical university and accounts for the single largest share of all academic medical research conducted in Sweden. Founded in 1810, KI is a public government university headquartered in Solna with additional campuses in Flemingsberg, co-located with Karolinska University Hospital. It educates medical and health sciences students at undergraduate, graduate, and doctoral levels, conducts biomedical research across the full medical spectrum, and hosts the Nobel Assembly responsible for awarding the Nobel Prize in Physiology or Medicine. KI's core technological platforms include multi-omics research infrastructure, the Karolinska ATMP Center for cell and gene therapy development, the KI Biobank (500,000+ donor samples), the Genomic Medicine Center, and the newly inaugurated Centre for AI Innovation.
KI operates an array of specialized research centers that translate discovery into clinical and commercial outcomes: the Karolinska ATMP Center (one of Europe's leading cell and gene therapy hubs), the Precision Medicine Center Karolinska, the Centre for Health Crises (medical preparedness, disaster, and defence medicine), and the Centre for AI Innovation. Notable research outputs include a gene therapy restoring sight in 11 of 12 hereditary blindness patients, the Stockholm3 blood test achieving 90% prostate cancer detection versus 74% for standard PSA, AI-driven antibiotic discovery against drug-resistant gonorrhoea published in Science Translational Medicine, and 82.5% successful desensitization in preschool peanut allergy trials.
KI's business model is that of a public-sector research university rather than a commercial enterprise. Revenue is derived from Swedish government appropriations, competitive research grants (European Research Council, EU Horizon, Wallenberg Foundation, Swedish Research Council), philanthropic donations, and tuition from non-EU/EEA students. Education for EU/EEA students is government-subsidized. The institution owns a wholly-owned investment subsidiary, Karolinska Development, which manages a portfolio of life science companies. Recent major capital inflows include a SEK 1.6 billion Wallenberg Foundation allocation, SEK 80 million from the Gysell family for prostate cancer research, EUR 5 million in ERC Advanced Grants, USD 9 million from the Leducq Foundation, and SEK 123 million in Swedish government funding for precision medicine and medical preparedness.
Karolinska Institutet firmographics
Firmographics- Name
- Karolinska Institutet
- Legal name
- Karolinska Institutet
- Website
- https://ki.se
- Company type
- Private
- Founded year
- 1810
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Karolinska Institutet is Sweden's largest medical university, conducting the single largest share of the country's academic medical research, hosting the Nobel Assembly, and educating medical students across campuses in Solna and Flemingsberg.
- Ownership category
- akta.pro rank
Karolinska Institutet industry classification
Industry- Product category
- Medical Research and Health Sciences Education
- NAICS
- Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310), Professional, Scientific, and Technical Services (541)
- SIC
- Services-Educational Services (8200), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Medical Schools (MD/DO Granting) (EDAHAGAB)
- akta.pro secondary industries
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Global Health Institutes & Programs (EDAHAGAM)
Keywords
Where Karolinska Institutet is headquartered
LocationHeadquarters
- HQ city
- Solna
- HQ country
- Sweden
- HQ region
- Europe
Offices3 records
Markets served
Karolinska Institutet business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Government funding: Primary revenue from Swedish government appropriations for higher education and research, representing the largest share of academic medical research funding in Sweden
- Research grants: Competitive research funding from Swedish Research Council, European Research Council (ERC), European Union Horizon programs, Wallenberg Foundations, and other international funding bodies
- Philanthropic donations: Private donations for specific research initiatives, such as SEK 80 million from Björn Gysell family for prostate cancer research and SEK 30 million for advanced prostate cancer therapies
- Government precision medicine investment: Swedish government SEK 63 million investment supporting Precision Medicine Center Karolinska and regional centers for advanced diagnostics integration
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Swedish/EU students - No tuition fees, government-funded education |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Karolinska Institutet product offering
Product offeringCore offering
Karolinska Institutet is Sweden's largest medical university, offering the largest portfolio of medical and health sciences degree programs in the country and conducting the single largest share of academic medical research in Sweden. Its offerings span undergraduate and doctoral education, biomedical and clinical research across all medical disciplines, advanced therapy medicinal products (ATMP), precision medicine, and AI-driven medical innovation.
Product overview
Karolinska Institutet is Sweden's largest medical university offering a portfolio of research centers and initiatives rather than commercial products. Key offerings include the Karolinska ATMP Center for cell and gene therapy development, the Centre for AI Innovation for medical AI research, the Precision Medicine Center Karolinska for personalized healthcare, and the KI Research Incubator (KIRI) for researcher innovation support. The institution also conducts extensive clinical research through partnerships with healthcare providers.
Differentiator
Problem solved
Functional benefit
Brands
- Centre for AI Innovation: A center inaugurated in 2025 to accelerate development and adoption of trustworthy AI in medical research and healthcare through collaboration, health data access, testing environments, and strategic alliances
- Precision Medicine Center Karolinska
- Centre for Health Crises
- Karolinska ATMP Center
- Centre of Excellence for Sustainable Health
Products and services
- Medical and Health Sciences Degree Programs Largest portfolio of medical and health sciences degree programs in Sweden, including undergraduate medicine, dentistry, nursing, biomedicine, allied health professions, master's and doctoral programs, with EU/EEA students receiving government-subsidized tuition.
- Karolinska ATMP Center Center facilitating collaboration between healthcare, universities, and pharmaceutical companies for the development, manufacturing, and delivery of cell and gene therapies (Advanced Therapy Medicinal Products).
- Centre for AI Innovation Center bringing together researchers, clinicians, policymakers, and industry partners to accelerate the development and adoption of trustworthy AI in medical research and healthcare through collaboration, health data access, testing environments, and strategic alliances.
- Precision Medicine Center Karolinska Center focused on developing long-term, equitable integration of advanced diagnostics and personalized treatment into healthcare, including precision diagnostics and personalized therapy across Sweden.
- Centre for Health Crises Multidisciplinary platform consolidating KI's activities in medical preparedness, covering health crises, disaster medicine, and defence-related medicine.
- Centre of Excellence for Sustainable Health Collaboration between Karolinska Institutet and Makerere University in Uganda focused on sustainable health systems, producing 64 PhD graduates, over 500 peer-reviewed publications, and more than 400 student and lecturer exchanges.
- Executive Programme in International Politics and Diplomacy for Health Executive education program jointly hosted with Stockholm School of Economics that brings together emerging health leaders from government, civil society, academia, and the private sector to build diplomatic skills for global health.
- KI Biobank Biological sample repository storing samples from over 500,000 donors, including the Biobank of Karolinska Endarterectomies, supporting large-scale multi-omics and clinical research programs.
Quantifiable outcome
- 90% detection rate for aggressive prostate cancer vs 74% for standard PSA test using Stockholm3 blood test
- +2 more outcomes
Companies that use Karolinska Institutet
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Karolinska Institutet technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature5 records
Karolinska Institutet partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- Stockholm School of EconomicscoreJoint Executive Programme in International Politics and Diplomacy for Health masterclass in Sigtuna, Sweden, bringing together 33 emerging health leaders from government, civil society, academia, and private sector to build diplomatic skills for global health
- FORTIFY (34-partner public-private initiative)core34-partner initiative funded by Innovative Health Initiative aligned with European Health Data Space, developing legal guidance, governance tools, and technical solutions for IP-sensitive secondary use of health data across Europe (May 2026 - April 2029)
- Institute of Applied Biosciences (INAB) at CERTH, GreececoreFormal partnership agreement strengthening academic cooperation in research, education, and innovation, building on 20+ years of collaboration focused on cancer research and hematological malignancies including joint projects, staff exchange, and educational programs
- TikoMed ABminorLetter of intent signed for ILBIAMI clinical study evaluating ILB effect in limiting heart muscle damage following myocardial infarction; KI serves as study sponsor while TikoMed provides active product and scientific support
- NeurotechEU University AlliancecoreEurope-wide doctoral network connecting researchers in neurotechnology, offering online activities, on-site meetings, workshops, courses, and peer exchange; KI serves as application recipient for the network
- Novo NordiskcoreStrategic partnership since 2019 for multi-omics research on unstable atherosclerosis; collaboration includes EU Horizon NextGen project for improved patient stratification and novel therapeutic targets
- Makerere University, Ugandacore25-year collaboration producing 64 PhD graduates, over 500 peer-reviewed publications, and more than 400 student and lecturer exchanges; partnership delivers practical health improvements from midwifery training to stroke rehabilitation
- St. Erik Eye HospitalcoreExpanded collaboration on Advanced Therapy Medicinal Products (ATMP) to accelerate transition of cell- and gene-based therapies from research to clinical application, focusing on retinal diseases; anchored at Karolinska ATMP Center
- MITcoreInternational collaboration on AI-driven antibiotic discovery where KI researchers contributed proteomics-based methods to identify compound mechanism of action against gonorrhoea bacteria
- KTH Royal Institute of TechnologycoreJoint research with KTH to create insulin-producing cells from human stem cells for Type 1 diabetes treatment; lab-grown cells successfully responded to glucose and restored blood sugar control in diabetic mice
- Columbia UniversityminorCollaborative study on organ transplantation rates among celiac disease patients finding three-fold higher transplantation rates compared to general population
- Swedish emergency preparedness systemcoreSEK 60 million investment for new thematic platform consolidating KI activities in medical preparedness including health crises, disaster medicine, and defence-related medicine; aims to position KI as knowledge hub
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
Karolinska Institutet competitors and assessment
Company assessmentBroad incumbents
- Imperial College London Faculty of Medicine: Major UK medical school with comparable translational research model integrated with NHS hospitals; competes for EU/UK research grants and international student pipeline.
- Harvard Medical School: Global benchmark for academic medical research with affiliated teaching hospitals; comparable in MD-granting, biomedical research output, and Nobel-affiliated faculty, with a substantially larger endowment.
- University of Oxford Medical Sciences Division: Top European competitor medical school with comparable MD programs, biomedical research output, and industry partnerships; competes for ERC funding and global recruitment of early-career researchers.
- ETH Zurich: European technical/STEM research powerhouse; a peer through its life sciences and bioengineering departments, and as a competing institution for international research talent and EU framework funding.
Direct peers
- Karolinska University Hospital: Affiliated teaching hospital co-located with KI; both share faculty, conduct joint clinical research, and operate as an integrated academic medical center — the closest operational peer given direct translational coupling.
- Lund University Faculty of Medicine: Sweden's second major medical faculty and recipient of Wallenberg Centre for Molecular Medicine funding; directly competes with KI for Swedish government research appropriations, ERC grants, and clinical research talent.
- Uppsala University Faculty of Medicine: One of Sweden's oldest and largest medical faculties; competes with KI for Swedish research funding, graduate students, and Nobel Assembly representation.
- Gothenburg University Sahlgrenska Academy: Sweden's third major medical faculty; directly competes for ALF-medel government funding, medical students, and clinical research partnerships with Sahlgrenska University Hospital.
- KTH Royal Institute of Technology: KI's joint research partner on insulin-producing stem cells for Type 1 diabetes; fellow Swedish public research institution and close collaborator with overlapping life science capabilities and faculty.
- Karolinska Development: Wholly-owned investment subsidiary of KI that manages and develops life science portfolio companies emerging from KI research; closely linked commercial translation arm that monetizes KI discoveries.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights8 records
Customer concentration
Karolinska Institutet social profiles
Digital presenceKarolinska Institutet compliance and trust
Trust signalCompliance2 records
Karolinska Institutet financial estimates
Financial estimateRevenue estimate
Valuation estimate
Karolinska Institutet leadership team
Management profileNumber of profiles
Profiles8 records
Karolinska Institutet subsidiaries and ownership
Company hierarchySubsidiaries1 record
Karolinska Institutet funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Karolinska Institutet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Karolinska Institutet
What does Karolinska Institutet do?
Karolinska Institutet is Sweden's largest medical university, offering the largest portfolio of medical and health sciences degree programs in the country and conducting the single largest share of academic medical research in Sweden. Its offerings span undergraduate and doctoral education, biomedical and clinical research across all medical disciplines, advanced therapy medicinal products (ATMP), precision medicine, and AI-driven medical innovation.
Is Karolinska Institutet a public or private company?
Karolinska Institutet is a private company. It is classified as state government owned and is currently operating.
When was Karolinska Institutet founded?
Karolinska Institutet was founded in 1810. It employs 1,001 to 5,000 people.
Where is Karolinska Institutet based?
Karolinska Institutet is headquartered in Solna, Sweden, in the Europe region.
How does Karolinska Institutet make money?
Four revenue lines are on record. Government funding is the primary driver. The others are research grants, philanthropic donations and government precision medicine investment.
Who are Karolinska Institutet's main competitors?
Broad incumbents on record are Imperial College London Faculty of Medicine, Harvard Medical School, University of Oxford Medical Sciences Division and ETH Zurich. Direct peers are Karolinska University Hospital, Lund University Faculty of Medicine, Uppsala University Faculty of Medicine, Gothenburg University Sahlgrenska Academy, KTH Royal Institute of Technology and Karolinska Development.
Does Karolinska Institutet have an API?
No public API is recorded for Karolinska Institutet.
What industry is Karolinska Institutet in?
Karolinska Institutet's product category is Medical Research and Health Sciences Education. Its primary akta.pro industry code is EDAHAGAB, Medical Schools (MD/DO Granting), with a secondary code of EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based). Its NAICS code is 6113 and its SIC code is 8200.